Summit Therapeutics CEO Glyn Edwards to present at San Francisco conference

Writer, Stock Market Wire
Wednesday, October 16, 2019 - 13:11

Summit Therapeutics said chief executive Glyn Edwards would present at an industry conference in San Francisco.

Edwards would present at the 2019 BIO Investor Forum on 22 October.

At 1:11pm: (LON:SUMM) Summit Therapeutics PLC share price was -0.5p at 23p

Related content

Summit Therapeutics losses deepen on higher R&D spend

Pharmaceutical company Summit Therapeutics posted a deeper second-quarter loss amid a rise in R&D spending.

Pre-tax losses for the three months through September amounted to...

Fri, 11/10/2019 - 13:52

Summit Therapeutics highlights potential of gonorrhoea treatment at key conference

Summit Therapeutics said that it had highlighted the potential of its pre-clinical new class antibiotic to treat all gonorrhoea, including multi-drug resistant strains, at the...

Wed, 17/07/2019 - 13:08

Summit Therapeutics books first-quarter loss on higher R&D spend

Antibiotics developer Summit Therapeutics booked a first-quarter loss as it ramped up R&D spending.

Pre-tax losses for the three months through March amounted to...

Wed, 12/06/2019 - 13:09

Summit Therapeutics presents antibiotic concept data at Amsterdman conference

Summit Therapeutics said it had presented proof of concept data for a series of new antibiotics at a conference in Amsterdam.

The data was presented...

Mon, 15/04/2019 - 08:06

Summit Therapeutics swings to profit

Summit Therapeutics swung to an annual profit as it continued to develop its antibiotic portfolio.

Pre-tax profit for the year through amounted to £5.0m, compared...

Wed, 27/03/2019 - 13:22